The characterization of a novel V1b antagonist lead series

被引：3
|
作者：
Smethurst, Chris A. [1 ]
Borthwick, Jennifer A. [1 ]
Gaines, Simon [1 ]
Watson, Steve [1 ]
Green, Andrew [1 ]
Schulz, Mark J.
Burton, George
Buson, Alberto A. [2 ]
Arban, Roberto [2 ]
机构：
[1] GlaxoSmithKline Res & Dev Ltd, Harlow, Essex, England
[2] GlaxoSmithKline Res & Dev Ltd, Verona, Italy
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 01期
关键词：
Vasopressin; Anxiety; Depression; VASOPRESSIN; STRESS;
D O I：
10.1016/j.bmcl.2010.11.061
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The SAR around a V1b antagonist HTS hit 3 was explored to produce a series of thiazole sulfonamides as a lead series with selectivity over the related V1 and oxytocin receptors. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：92 / 96
页数：5
相关论文
共 50 条
  • [21] The discovery of novel vasopressin V1b receptor ligands for pharmacological, functional and structural investigations
    Guillon, G
    Derick, S
    Pena, A
    Cheng, LL
    Stoev, S
    Seyer, R
    Morgat, JL
    Barberis, C
    Serradeil-Le Gal, C
    Wagnon, J
    Manning, M
    JOURNAL OF NEUROENDOCRINOLOGY, 2004, 16 (04) : 356 - 361
  • [22] Use of a specific vasopressin V1b receptor antagonist (SSR149415) in sheep pituitary cells.
    Carey, LC
    Rose, JC
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2006, 13 (02) : 101A - 101A
  • [23] Regulation of vasopressin V1b receptors and stress adaptation
    Volpi, S
    Rabadán-Diehl, C
    Aguilera, G
    STRESS: CURRENT NEUROENDOCRINE AND GENETIC APPROACHES, 2004, 1018 : 293 - 301
  • [24] Fluorescent agonists for the human vasopressin V1b receptor
    Guillon, G.
    Murat, B.
    Corbani, M.
    Boulay, V
    Stoev, S.
    Manning, M.
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 116 - 116
  • [25] Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression
    Hodgson, R. A.
    Higgins, G. A.
    Guthrie, D. H.
    Lu, S. X.
    Pond, A. J.
    Mullins, D. E.
    Guzzi, M. F.
    Parker, E. M.
    Varty, G. B.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2007, 86 (03) : 431 - 440
  • [26] Vasopressin V1B Receptor Antagonists as Potential Antidepressants
    Chaki, Shigeyuki
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (06): : 450 - 463
  • [27] Subcellular localization and internalization of the vasopressin V1B receptor
    Kashiwazaki, Aki
    Fujiwara, Yoko
    Tsuchiya, Hiroyoshi
    Sakai, Nobuya
    Shibata, Katsushi
    Koshimizu, Taka-aki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 765 : 291 - 299
  • [28] SSR149415, a nonpeptide V1b receptor antagonist with antidepressant activities improves memory in stressful conditions
    Urani, A.
    Bergis, O. E.
    Griebel, G.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S20 - S20
  • [29] SSR149415, a V1b receptor antagonist, inhibits stress-induced visceral hypersensitivity in rats
    Ferrier, Laurent
    Gaultier, Eric
    Gal, Claudine Serradeil-Le
    Pascal, Marc
    Bueno, Lionel
    GASTROENTEROLOGY, 2008, 134 (04) : A544 - A544
  • [30] PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) ANALYSES OF ARGININE VASOPRESSIN TYPE-1B (V1B) RECEPTOR ANTAGONIST EFFECT ON CORTISOL.
    Singh, I.
    Liu, W.
    Katz, D. A.
    Awni, W. M.
    Dutta, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S87 - S87
12345